Academics criticize World Athletics' mandatory genetic testing for female athletes

A group of academics has condemned World Athletics' policy of mandatory SRY gene testing for female track and field athletes as a harmful anachronism. The testing, introduced last September, aims to ensure only biologically female individuals compete at the elite level. Critics argue it violates human rights and lacks scientific grounding.

World Athletics implemented mandatory testing for the SRY gene in female track and field athletes last September. The policy seeks to confirm that competitors are biologically female, thereby maintaining the integrity of women's events at the elite level. Sebastian Coe, president of World Athletics, explained that the measure was designed to "protect and promote the integrity of women’s sport."

In response, 34 academics, led by figures including Professor Alun Williams, have issued a report denouncing the policy as a "backwards step" and "harmful anachronism." They contend that the approach oversimplifies the concept of sex and could lead to stigma and distress for athletes. The report emphasizes that there is insufficient robust data connecting the SRY gene directly to performance advantages in athletics, and it raises concerns about violations of athletes' human rights.

World Athletics has pushed back against the criticism, maintaining that the policy safeguards the human rights of female athletes overall. The organization cites extensive research demonstrating the performance advantages held by biological males in sports. This debate highlights ongoing tensions in elite athletics over fairness, inclusion, and scientific evidence in regulating competition categories.

The academics' intervention comes amid broader discussions on how governing bodies balance competitive equity with individual rights in women's sports.

관련 기사

IOC officials discussing eligibility rules for women's events in a conference room with Olympic symbols.
AI에 의해 생성된 이미지

IOC studies stricter eligibility rules for women’s category; says no decision yet on transgender participation

AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨

The International Olympic Committee is reviewing eligibility rules for women’s events and weighing tighter, science‑based criteria, but says no decision has been made amid reports of a potential ban to be considered ahead of the Milan‑Cortina 2026 Winter Games.

A new book by bioethicist Daphne O. Martschenko and sociologist Sam Trejo explores the implications of polygenic scores in genetic testing, highlighting potential inequalities and myths surrounding genetics. Through their 'adversarial collaboration,' the authors debate whether such research can promote equity or entrench social divides. They call for stricter regulation to ensure responsible use.

AI에 의해 보고됨

The U.S. Supreme Court heard oral arguments on January 13, 2026, in two cases challenging state laws in West Virginia and Idaho that bar transgender women from competing in women's sports. Justices expressed skepticism about the challengers' claims that the laws violate the Equal Protection Clause and Title IX. Outside the court, hundreds rallied in support of protecting women's sports.

The U.S. Department of Education and the Department of Justice said January 15, 2026, that their Title IX Special Investigations Team has opened an investigation into the California Community College Athletic Association over a policy allowing certain transgender and non-binary athletes to compete on women’s teams after at least one year of testosterone suppression treatment.

AI에 의해 보고됨

The CEO of fitness tracker company Whoop has publicly condemned the Australian Open for forcing tennis players to remove its wearable devices. Describing the decision as 'ridiculous,' the executive argued that 'data is not steroids.' This controversy highlights tensions between sports regulations and wearable technology.

Several top tennis players, including Carlos Alcaraz, Jannik Sinner and Aryna Sabalenka, were asked to remove wearable fitness trackers during the Australian Open 2026. The devices, approved by the ITF and tours, are not permitted at Grand Slams. Players expressed frustration, hoping for a policy change to monitor health and performance.

AI에 의해 보고됨

홍콩 보건 당국이 중국 본토에서 태아 성별 검사용 혈액 샘플의 불법 수입 의혹을 조사 중이며, 두 실험실이 연루됐다. 이 사건은 대륙 임산부를 대상으로 한 소셜 미디어 채혈 홍보에 대한 언론 문의로 드러났다.

 

 

 

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부